Full View

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

CL Grandjean, Z Garcia, F Lemaître, B Bréart… - Science …, 2021 - science.org
Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …
被引用次数：21 相关文章

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

C Grandjean, Z Garcia, F Lemaître, B Bréart… - Science …, 2021 - hal.science
Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …

[引用][C] Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

CL Grandjean, Z Garcia, F Lemaître… - Science …, 2021 - ui.adsabs.harvard.edu
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in
antibody-dependent phagocytosis - NASA/ADS Now on home page ads icon ads Enable full ADS …

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis.

CL Grandjean, Z Garcia, F Lemaître, B Bréart… - Science …, 2021 - europepmc.org
Abstract Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …
[PDF] researchgate.net

[PDF][PDF] Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

CL Grandjean, Z Garcia, F Lemaître, B Bréart… - 2021 - researchgate.net
Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …
[HTML] nih.gov

[HTML][HTML] Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

CL Grandjean, Z Garcia, F Lemaître, B Bréart… - Science …, 2021 - ncbi.nlm.nih.gov
Abstract Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

C Grandjean, Z Garcia, F Lemaître, B Bréart… - Science …, 2021 - pasteur.hal.science
Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

CL Grandjean, Z Garcia, F Lemaître… - Science …, 2021 - pubmed.ncbi.nlm.nih.gov
Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis.

CL Grandjean, Z Garcia, F Lemaître, B Bréart… - Science …, 2021 - europepmc.org
Abstract Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …
[PDF] hal.science

[PDF][PDF] Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

CL Grandjean, Z Garcia, F Lemaître, B Bréart… - 2021 - hal.science
Anti-CD20 antibody (mAb) represents an effective strategy for the treatment of B cell
malignancies, possibly involving complement activity, antibody-dependent cellular …